Response to pre-radiation chemotherapy as a predictor of survival in patients with newly diagnosed malignant astrocytoma: A north central cancer treatment group (NCCTG) study

被引：0
|
作者：
Jaeckle, K
Ballman, K
O'Fallon, J
Scheithauer, B
Giannini, C
Moynihan, T
Buckner, J
机构：
[1] Mayo Clin, Jacksonville, FL USA
[2] Mayo Clin, Rochester, MN USA
来源：
NEURO-ONCOLOGY | 2004年 / 6卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：376 / 376
页数：1
相关论文
共 50 条
  • [41] North Central Cancer Treatment Group phase II study of panitumumab (Pmab), chemotherapy, and external beam radiation (Chemo-RT) in patients with locally advanced (LA) pancreatic cancer
    Kim, George P.
    Foster, Nathan R.
    Haddock, Michael G.
    Bollinger, John William
    Dakhil, Shaker R.
    Behrens, Robert J.
    Flynn, Patrick J.
    Steen, Preston D.
    Bury, Martin Joseph
    Stella, Philip J.
    Alberts, Steven R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [42] Comorbidity in newly diagnosed thyroid cancer patients: a population-based study on prevalence and the impact on treatment and survival
    Kuijpens, JLP
    Janssen-Heijnen, MLG
    Lemmens, VEPP
    Haak, HR
    Heijckmann, AC
    Coebergh, JWW
    CLINICAL ENDOCRINOLOGY, 2006, 64 (04) : 450 - 455
  • [43] Pre-Chemotherapy Levels of Hemostatic Biomarkers and Prediction of Prognosis in Newly Diagnosed Metastatic Cancer Patients from the Hypercan Study
    Falanga, Anna
    Giaccherini, Cinzia
    Verzeroli, Cristina
    Marchetti, Marina
    Russo, Laura
    Masci, Giovanna
    Celio, Luigi
    Merelli, Barbara
    Sarmiento, Roberta
    Ghilardi, Mara
    Tartari, Carmen J.
    Brevi, Shenaz
    Caldara, Gloria
    Gamba, Sara
    Malighetti, Paolo
    Spinelli, Daniele
    Santoro, Armando
    De Braud, Filippo
    Gasparini, Giampietro
    Giuliani, Francesco
    Barni, Sandro
    D'Alessio, Andrea
    Labianca, Roberto
    BLOOD, 2018, 132
  • [44] Pharmacokinetic analysis of imatinib and CGP74588 in patients with recurrent anaplastic oligodendroglioma: North central cancer treatment group (NCCTG) N0272
    Jaeckle, Kurt
    Egorin, Merrill
    Anderson, S. Keith
    Wu, Wenting
    Sarkaria, Jann
    Galanis, Evanthia
    Brown, Paul
    Murgo, Anthony
    Buckner, Jan
    NEURO-ONCOLOGY, 2007, 9 (04) : 563 - 563
  • [45] Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials
    Wang, Xiaofei
    Wang, Xiaoyi
    Hodgson, Lydia
    George, Stephen L.
    Sargent, Daniel J.
    Foster, Nate R.
    Ganti, Apar Kishor
    Stinchcombe, Thomas E.
    Crawford, Jeffrey
    Kratzke, Robert
    Adjei, Alex A.
    Kindler, Hedy L.
    Vokes, Everett E.
    Pang, Herbert
    ONCOLOGIST, 2017, 22 (02): : 189 - 198
  • [46] Phase I study of temsirolimus (CCI-779) and sorafenib in recurrent glioblastoma: North central cancer treatment group (NCCTG) N0572
    Schiff, David
    Sarkaria, Jann
    Decker, Paul
    Buckner, Jan
    Galanis, Evanthia
    Dancey, Janet
    Giannini, Caterina
    Brown, Paul
    Wiesenfeld, Martin
    Jaeckle, Kurt
    NEURO-ONCOLOGY, 2007, 9 (04) : 518 - 518
  • [47] Incidence of bleeding and thrombosis among elderly patients (pts) undergoing systemic chemotherapy in advanced non-small cell lung cancer (NSCLC): An analysis of North Central Cancer Treatment Group (NCCTG) trials.
    Qi, Y.
    Dy, G. K.
    Nelson, G. D.
    Schild, S. E.
    Mandrekar, S. J.
    Adjei, A. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-Small-Cell Lung Cancer North Central Cancer Treatment Group (NCCTG)-N0321
    Zhao, Yujie
    Foster, Nathan R.
    Meyers, Jeffrey P.
    Thomas, Sachdev P.
    Northfelt, Donald W.
    Rowland, Kendrith M., Jr.
    Mattar, Bassam I.
    Johnson, David B.
    Molina, Julian R.
    Mandrekar, Sumithra J.
    Schild, Steven E.
    Bearden, James D., III
    Aubry, Marie-Christine
    Adjei, Alex A.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (01) : 172 - 180
  • [49] Primary central nervous system non-Hodgkin's lymphoma (PCNSL): Survival advantages with combined initial therapy? A final report of the North Central Cancer Treatment Group (NCCTG) study 86-72-52
    O'Neill, BP
    Wang, CH
    O'Fallon, JR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (03): : 559 - 563
  • [50] Improved Survival with Delivery of Pelvic Radiation in Addition to Chemotherapy Versus Chemotherapy Alone in Newly Diagnosed Stage IV Anal Squamous Cell Carcinoma: A National Cancer Database Study
    Ghiassi-Nejad, Z.
    Sigel, K.
    Lazarev, S.
    Buckstein, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E149 - E149
12345